Skip to main content

Together we are beating cancer

Donate now

Health & Medicine

Find out more about the latest cancer treatments, clinical trials, cancer prevention and health policy
Showing 12 out of 3487 results
3D rendering of oesophageal cancer

The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer. The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for some patients with advanced oesophageal cancer.

by Harry Jenkins | News | 11 August 2021

11 August 2021

  • Science & Technology
  • For Researchers
  • Health & Medicine

Why people and culture matter in research

We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers

by Cancer Research UK | Research Feature | 10 August 2021

10 August 2021

Clinician holds hand of patient on hospital bed.

Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK. Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK.

by Cancer Research UK | News | 5 August 2021

5 August 2021

Lung cancer CT scan

1 in 2 people in the UK will be diagnosed with some form of cancer during their lifetime. We’ve estimated the impact different types of activity could make to ambitions to diagnose cancer earlier. 1 in 2 people in the UK will be diagnosed with some form of cancer during their lifetime. We’ve estimated the impact different types of activity could make to ambitions to diagnose cancer earlier.

by Hope Walters | Analysis | 27 July 2021

27 July 2021

A transgender woman in a hospital gown speaking to her doctor, a transgender man, in an exam room.

LGBTQIA+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQIA+ people. LGBTQIA+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQIA+ people.

by Harry Jenkins | Analysis | 26 July 2021

26 July 2021

The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy. The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy.

by Harry Jenkins | News | 22 July 2021

22 July 2021

Two people in a doctor's waiting room

A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic. A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic.

by Cancer Research UK | News | 16 July 2021

16 July 2021

A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible. A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.

by Harry Jenkins | Analysis | 14 July 2021

14 July 2021

Woman refuses more red wine

1 in 25 newly diagnosed cancer cases in the last year may be associated with drinking alcohol, according to a global study published in The Lancet Oncology. 1 in 25 newly diagnosed cancer cases in the last year may be associated with drinking alcohol, according to a global study published in The Lancet Oncology.

by Harry Jenkins | News | 14 July 2021

14 July 2021